Humana Inc. (NYSE:HUM) Holdings Boosted by AGF Management Ltd.

AGF Management Ltd. boosted its holdings in Humana Inc. (NYSE:HUM) by 17.7% during the second quarter, HoldingsChannel.com reports. The fund owned 7,382 shares of the insurance provider’s stock after acquiring an additional 1,111 shares during the period. AGF Management Ltd.’s holdings in Humana were worth $2,758,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of the business. Mendota Financial Group LLC lifted its holdings in Humana by 9.2% in the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after acquiring an additional 27 shares during the last quarter. Aurora Investment Counsel lifted its holdings in Humana by 1.3% in the fourth quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock worth $1,155,000 after acquiring an additional 29 shares during the last quarter. Capital Advisors Ltd. LLC increased its stake in shares of Humana by 17.0% in the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock valued at $80,000 after purchasing an additional 31 shares during the period. EP Wealth Advisors LLC increased its stake in shares of Humana by 1.6% in the fourth quarter. EP Wealth Advisors LLC now owns 2,294 shares of the insurance provider’s stock valued at $1,050,000 after purchasing an additional 37 shares during the period. Finally, CarsonAllaria Wealth Management Ltd. increased its stake in shares of Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Trading Down 1.1 %

Shares of NYSE:HUM opened at $324.50 on Friday. The company has a 50 day moving average price of $365.05 and a 200 day moving average price of $347.04. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. The stock has a market capitalization of $39.10 billion, a price-to-earnings ratio of 20.21, a PEG ratio of 2.80 and a beta of 0.50.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm had revenue of $29.54 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same quarter last year, the business posted $8.94 EPS. The company’s revenue was up 10.4% on a year-over-year basis. On average, research analysts anticipate that Humana Inc. will post 16 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio is 22.04%.

Analysts Set New Price Targets

Several brokerages have commented on HUM. Truist Financial raised their price target on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a research note on Monday, July 15th. Morgan Stanley began coverage on shares of Humana in a research note on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price target on the stock. TD Cowen raised their price target on shares of Humana from $396.00 to $407.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Bank of America raised their price target on shares of Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a research note on Monday, May 20th. Finally, Oppenheimer raised their price objective on shares of Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a research note on Thursday, August 1st. Thirteen analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, Humana has an average rating of “Hold” and an average target price of $398.70.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.